Teleflex (TFX)
(Delayed Data from NYSE)
$242.50 USD
-3.18 (-1.29%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $242.37 -0.13 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
Company Summary
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has approximately 35 manufacturing sites with major manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Following the acquisition of Vascular ...
Company Summary
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has approximately 35 manufacturing sites with major manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Following the acquisition of Vascular Solutions in 2017, Teleflex currently has seven reportable segments:
Vascular Access (23.8% of total revenues in 2023, up 3.6% from 2022): Vascular access business which offers products that facilitate a variety of critical care therapies and other applications.
Interventional (17.2%, up 14.9%): This segment is comprised of the North American component of the company’s acquired Vascular Solutions business, as well as interventional access and cardiac care businesses.
Anesthesia (13.1%, up 0.3%): This segment is comprised of North American pain management and airway management products and other products.
Surgical (14.4%, up 8.8%): The segment includes a comprehensive range of devices for use in a variety of surgical procedures.
Interventional Urology (10.8%, down 0.9%): This segment provides medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals/ healthcare providers, and home health.
Original Equipment Manufacturer and Development Services (OEM) (11%, up 19.6%): This segment designs, manufactures and supplies devices and instruments for other medical device manufacturers.
Other (9.8%, up 2.4%): The segment includes single-use respiratory products and also has an operating segment, encompassing the company’s Latin American business.
General Information
Teleflex Incorporated
550 E SWEDESFORD RD Suite 400
WAYNE, PA 19087
Phone: 610-225-6800
Fax: 215-553-5402
Email: investor.relations@teleflex.com
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/7/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 3.38 |
Current Year EPS Consensus Estimate | 13.97 |
Estimated Long-Term EPS Growth Rate | 7.90 |
Exp Earnings Date | 11/7/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 245.68 |
52 Week High | 257.85 |
52 Week Low | 177.63 |
Beta | 1.16 |
20 Day Moving Average | 256,860.75 |
Target Price Consensus | 265.25 |
4 Week | 1.43 |
12 Week | 17.02 |
YTD | -2.74 |
4 Week | -0.91 |
12 Week | 12.51 |
YTD | -17.74 |
Shares Outstanding (millions) | 47.12 |
Market Capitalization (millions) | 11,425.87 |
Short Ratio | NA |
Last Split Date | 6/17/1997 |
Dividend Yield | 0.56% |
Annual Dividend | $1.36 |
Payout Ratio | 0.10 |
Change in Payout Ratio | -0.01 |
Last Dividend Payout / Amount | 8/15/2024 / $0.34 |
Fundamental Ratios
P/E (F1) | 17.36 |
Trailing 12 Months | 17.77 |
PEG Ratio | 2.20 |
vs. Previous Year | 0.29% |
vs. Previous Quarter | 6.54% |
vs. Previous Year | 0.87% |
vs. Previous Quarter | 1.60% |
Price/Book | 2.51 |
Price/Cash Flow | 12.88 |
Price / Sales | 3.80 |
6/30/24 | 14.51 |
3/31/24 | 14.78 |
12/31/23 | 14.98 |
6/30/24 | 8.63 |
3/31/24 | 8.79 |
12/31/23 | 8.87 |
6/30/24 | 2.58 |
3/31/24 | 2.51 |
12/31/23 | 2.32 |
6/30/24 | 1.44 |
3/31/24 | 1.41 |
12/31/23 | 1.29 |
6/30/24 | 21.49 |
3/31/24 | 21.51 |
12/31/23 | 21.50 |
6/30/24 | 8.76 |
3/31/24 | 9.82 |
12/31/23 | 11.98 |
6/30/24 | 9.35 |
3/31/24 | 10.35 |
12/31/23 | 14.59 |
6/30/24 | 96.75 |
3/31/24 | 95.61 |
12/31/23 | 94.49 |
6/30/24 | 2.11 |
3/31/24 | 2.12 |
12/31/23 | 2.13 |
6/30/24 | 0.36 |
3/31/24 | 0.37 |
12/31/23 | 0.39 |
6/30/24 | 26.27 |
3/31/24 | 27.03 |
12/31/23 | 28.01 |